Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADX10059 for prevention of migraine: phase 2b randomized dose-ranging trial
2008-005481-30Phase 2Terminated
- Sponsor
- Addex Therapeutics Ltd
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of raseglurant in migraine, sponsored by Addex Therapeutics Ltd. Started Oct 2008; status: terminated.
02
Drugs
raseglurant
03
Conditions
migraine
Beyond the preview
Go deeper on 2008-005481-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005481-30.